https://healthstockshub.com/news/nasdaq/ixhl/incannex-announces-positive-topline-results-from-phase-2-psi-gad1-clinical-trial-of-psilocybin-in-generalised-anxiety-disorder
- Forums
- ASX - By Stock
- IHL
- Trading on NASDAQ
Trading on NASDAQ, page-291
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)